Market Overview Crohn's disease is highly heterogeneous, meaning it manifests differently in every patient, and a drug that works perfectly for one individual might fail entirely for another. The US Crohn's Disease Market is moving rapidly toward a personalized medicine framework, leveraging advanced diagnostics to match patients with the optimal therapy right from the start. Current Market...